Marsh & McLennan Companies, Inc. (NYSE:MMC) Shares Acquired by Northwest & Ethical Investments L.P.
by Renee Jackson · The Cerbat GemNorthwest & Ethical Investments L.P. increased its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report) by 26.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 99,886 shares of the financial services provider’s stock after purchasing an additional 21,156 shares during the quarter. Northwest & Ethical Investments L.P.’s holdings in Marsh & McLennan Companies were worth $22,284,000 at the end of the most recent quarter.
Several other hedge funds also recently added to or reduced their stakes in the stock. Carmichael Hill & Associates Inc. grew its stake in Marsh & McLennan Companies by 85.7% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 130 shares of the financial services provider’s stock worth $29,000 after buying an additional 60 shares during the last quarter. Catalyst Capital Advisors LLC acquired a new position in shares of Marsh & McLennan Companies in the 3rd quarter valued at $31,000. Crewe Advisors LLC raised its position in Marsh & McLennan Companies by 100.0% in the 2nd quarter. Crewe Advisors LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 80 shares during the last quarter. Capital Performance Advisors LLP purchased a new position in Marsh & McLennan Companies during the 3rd quarter worth $41,000. Finally, Ridgewood Investments LLC purchased a new stake in Marsh & McLennan Companies in the 2nd quarter valued at approximately $41,000. 87.99% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research firms have commented on MMC. The Goldman Sachs Group set a $220.00 target price on Marsh & McLennan Companies and gave the stock a “sell” rating in a research report on Friday, October 18th. Barclays boosted their price target on Marsh & McLennan Companies from $236.00 to $246.00 and gave the company an “equal weight” rating in a report on Thursday, November 21st. Jefferies Financial Group lifted their price objective on Marsh & McLennan Companies from $219.00 to $222.00 and gave the company a “hold” rating in a research report on Wednesday, October 9th. Evercore ISI reiterated an “outperform” rating and set a $242.00 target price on shares of Marsh & McLennan Companies in a research report on Monday. Finally, Bank of America lifted their price target on Marsh & McLennan Companies from $248.00 to $250.00 and gave the company a “neutral” rating in a report on Thursday, October 10th. Two investment analysts have rated the stock with a sell rating, twelve have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, Marsh & McLennan Companies has an average rating of “Hold” and a consensus price target of $227.60.
Check Out Our Latest Research Report on MMC
Insiders Place Their Bets
In other Marsh & McLennan Companies news, Director Oscar Fanjul sold 2,500 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $221.55, for a total value of $553,875.00. Following the sale, the director now owns 48,549 shares in the company, valued at approximately $10,756,030.95. This trade represents a 4.90 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.35% of the stock is currently owned by company insiders.
Marsh & McLennan Companies Stock Up 0.2 %
Shares of NYSE:MMC traded up $0.46 during midday trading on Thursday, hitting $233.23. 1,349,553 shares of the company’s stock traded hands, compared to its average volume of 1,699,707. The firm’s fifty day moving average price is $223.89 and its two-hundred day moving average price is $219.40. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.14 and a current ratio of 1.14. Marsh & McLennan Companies, Inc. has a twelve month low of $184.28 and a twelve month high of $235.21. The company has a market cap of $114.54 billion, a PE ratio of 28.72, a P/E/G ratio of 2.78 and a beta of 0.94.
Marsh & McLennan Companies (NYSE:MMC – Get Free Report) last announced its earnings results on Thursday, October 17th. The financial services provider reported $1.63 EPS for the quarter, beating the consensus estimate of $1.61 by $0.02. Marsh & McLennan Companies had a return on equity of 32.65% and a net margin of 16.82%. The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.71 billion. During the same period last year, the business posted $1.57 EPS. The company’s revenue was up 5.9% on a year-over-year basis. On average, equities research analysts anticipate that Marsh & McLennan Companies, Inc. will post 8.68 EPS for the current fiscal year.
Marsh & McLennan Companies Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 4th were given a dividend of $0.815 per share. The ex-dividend date was Friday, October 4th. This represents a $3.26 annualized dividend and a dividend yield of 1.40%. Marsh & McLennan Companies’s payout ratio is 40.15%.
About Marsh & McLennan Companies
Marsh & McLennan Companies, Inc, a professional services company, provides advice and solutions to clients in the areas of risk, strategy, and people worldwide. It operates through Risk and Insurance Services, and Consulting segments. The Risk and Insurance Services segment offers risk management services, such as risk advice, risk transfer, and risk control and mitigation solutions, as well as insurance and reinsurance broking, strategic advisory services, and analytics solutions, and insurance program management services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- Basic Materials Stocks Investing
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- How to Buy Cheap Stocks Step by Step
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Why is the Ex-Dividend Date Significant to Investors?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding MMC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MMC – Free Report).